首页 | 官方网站   微博 | 高级检索  
     

大肠癌前哨淋巴结微转移的检测及其临床意义
引用本文:杨熊飞,王涛,张维胜,冯丽莉,杜斌斌,张艾莉.大肠癌前哨淋巴结微转移的检测及其临床意义[J].中国肛肠病杂志,2009(8):9-13.
作者姓名:杨熊飞  王涛  张维胜  冯丽莉  杜斌斌  张艾莉
作者单位:甘肃省人民医院肛肠科,甘肃兰州730000
基金项目:基金项目:甘肃省科技攻关项目(2GS064-B43-020-36)
摘    要:为探讨大肠癌前哨淋巴结(SLN)微转移(MM)的检测方法及其临床意义,我们对64例行根治性手术的DukesB期大肠癌患者SLN进行定位;应用常规HE染色联合免疫组化SIP法染色,对定位成功的122枚SLN中细胞角蛋白20(CK20)及端粒酶进行检测,并分析其表达与I临床病理因素的相关性。结果显示:(1)SLN定位成功61例(95.3%),共获取SLN122枚。(2)定位成功的61例中,有6例9枚SLN常规HE染色阳性;余55例113枚SLNHE染色阴性,其中免疫组化染色CK20阳性15例(27.3%),端粒酶阳性12例(21.8%),两者联合检测SLNMM阳性21例(38.2%)。(3)DukesB期大肠癌患者SLNMM(+)组癌的复发转移率明显高于同期SLNMM(-)组(P〈0.05),生存率明显降低(P〈0.05);而与DukesC期复发转移率及生存率比较,差异无统计学意义(P〉0.05)。(4)SLNMM(-)组患者的复发转移率、生存率与同期DukesC期患者比较,差异有统计学意义(P〈0.05)。(5)DukesB期大肠癌患者SLNMM的发生与患者年龄、性别及肿瘤侵犯肠管周径、生长方式、生长部位均无显著相关,而与肿瘤分化程度及大小、外周血癌胚抗原(CEA)值显著相关。结果表明,应用免疫组化法联合检测CK20和端粒酶,可提高大肠癌SLNMM的检出率;大肠癌SLNMM的检出能精确大肠癌的Dukes分期,有助于指导术后的辅助治疗和预后判断。

关 键 词:结直肠肿瘤  前哨淋巴结  微转移  细胞角蛋白20  端粒酶  免疫组织化学

Mapping and Detection of Sentinel Lymph Node Micrometastasis in Colorectal Carcinoma and Its Clinical Significance
Affiliation:Yang Xiongfei ,Wang Tao ,Zhang Weisheng , et al( Dept. of Coloproctology ,Peoples Hospital of Gansu Province ,Lanzhou,Gansu 730000)
Abstract:In order to investigate the detection method of sentinel lymph node(SLN)micrometastasis (MM) and its clinical significance,authors mapped and detected 122 SLNs successfully in 64 cases,who had Dukes B colorectal carcinoma and received radical procedure, using the routine hematoxylin eosin(HE) and immu- nohistochemical(IHC) staining to detect their cytokeratin 20(CK20) and telomerase in those SLNs,and to analize the correlation between the clinical pathological parameters and SLN MM. Results: (1)The SLNs were identified in 61 of 64 patients(95.3%),122 SLNs were retrieved; (2)Among the 61 patients,9 SLNs of 6 patients were positive,detected by the conventional HE staining; for the rest 113 SLNs in 55 patients HE stain negative, IHC(immunohistochemistry) was used to detect the micrometastasis. 15 cases(27.3%, 15/55) were CK20 postive in expression,and 12 (21.8%, 12/55) were telomerase positive in expression. Combiniation of the two methods could improve the SLN MM rate as 38.2% (21/55). (3)The percent of carcinoma recurrence or metastasis of the Dukes B patients with SLN MM (+) was significantly higher than the patients with SLN MM (-) ( P 〈 0.05), but the survival rate was significantly lower ( P 〈 0. 05). However,compared with Dukes C patients, the percents were of no significant difference. (4)The percents of recurrence or metastasis and survival between Dukes C and SLN MM (-) Dukes B patients were significantly different( P %0.05). (5) SLN MM of Dukes B eoloreetal carcinoma had no significant correlation with age, gender, intestinal tumor circumference, growth pattern and site of tumor growth, ex- cept for the degree of tumor differentiation,size and peripheral blood carcinoembryonic antigen (CEA) value. The results demonstrate that combiniation of CK20 and telomerase IHC can improve the SLN MM de- tection rate,mapping and detection of SLN MM can accurately confirm the Dukes stage of coloreetal careinoma,thus contribu
Keywords:Colorectal neoplasm  Sentinel lymph node  Micrometastasis  Cytokeratin 20  Telomerase  Immunohistochemistry
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号